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he word lentivirus has its root in the Latin 
“lentus,” which means slow or lingering — an apt 
description for the chronic, persistent infections the 
virus causes in animals and people.
For the past 25 years, Susan Carpenter has studied the 
genetic strategies that allow lentiviruses to linger.
The professor of animal science studies equine infectious 
anemia virus, a lentivirus that afflicts horses and is a close 
relative of human immunodeficiency virus, HIV. That makes 
it a good model to inform new vaccine strategies for HIV 
and other persistent viruses and prevent the progression to 
AIDS and some cancers.
“The ability of lentiviruses to continually evolve and 
escape immune control is the main obstacle in developing 
effective vaccines for HIV and other persistent infections,” 
she says.
With equine infectious anemia, the horse’s immune sys-
tem exerts some control over the lentivirus, although it can’t 
eliminate it.
In a way, it’s about prey and predator — a continually 
evolving virus in a continually adapting immune environ-
ment. Carpenter’s long-term studies explore the interplay 
between virus and host and how each tries to get the upper 
hand over time.
“How the virus persists in the face of a fairly effective 
immune response is something we want to know,” she says. 
“When a lentivirus can’t run, it hides in the genome. The 
knowledge we discover will help lead to the design of better, 
smarter vaccines that anticipate the virus’s next move.”
The research has earned support from the National 
Institutes of Health and USDA. Carpenter works with col-
leagues at ISU and at Washington State Universty, where a 
research herd of horses is maintained.
It’s a very integrated program, meshing expertise in molec-
ular viology with computational modeling, protein structure 
and function, veterinary pathology and other disciplines to 
understand disease from the molecular to the in vivo level.
“Integrating all these ways of thinking is key to under-
standing virus-host interactions,” Carpenter says.
She has found that the horse’s immune response im-
proves and broadens over time. At the same time, the wily 
lentivirus engages in a series of genetic tradeoffs to escape 
from attacking antibodies while maintaining its prime 
objective: replication.
“It’s like the lentivirus has a rheostat, dimming when it 
needs to evade attention and, after biding its time, brighten-
ing to optimize its survival.”
Does it sound like work that might leave a scientist shak-
ing her head? Think again.
“How do we find the will to keep going, is that the ques-
tion?” Carpenter says, laughing. “My perspective is that 
we’re trying to provide information to allow others to de-
velop better vaccines. We have a model system we can learn 
from, and figure out fundamental principles that can apply 
to a variety of diseases.”
What she finds rewarding is constantly taking discover-
ies at the molecular level and placing them within the big 
picture of the disease.
“It’s a puzzle, and scientists like solving puzzles. No 
matter how arcane the molecular interactions might 
become, you always put them into context of what’s going 
on in vivo.”   
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Better vaccine strategies for HIV may result from discoveries made in Susan 
Carpenter’s lab. Carpenter, graduate student Cierra Pairett (right) and research 
associate Hyelee Loyd (left) study DNA sequences to better understand immune 
response to a virus in horses that’s related to HIV.
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